JP Patent

JP7578585B2 — 骨髄線維症の血小板数非依存的処置方法

Assigned to GlaxoSmithKline LLC · Expires 2024-11-06 · 2y expired

What this patent protects

Patent listed against momelotinib-dihydrochloride.

Drugs covered by this patent

momelotinib-dihydrochloride (MOMELOTINIB DIHYDROCHLORIDE)

Patent Metadata

Patent number: JP7578585B2
Jurisdiction: JP
Classification: —
Expires: 2024-11-06
Drug substance claim: No
Drug product claim: No
Assignee: GlaxoSmithKline LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.